Federal Register Notice: FDA is making available a draft guidance for industry entitled Providing Submissions in Electronic Format — Postmarketing Safety Reports. It provides general information on electronic submission of postmarketing safety reports (individual case safety reports (ICSRs), ICSR attachments, and other postmarketing safety reports) for certain human drug and biological products. To download this draft guidance, click here. To view this notice, click here.